VZV ORF11 encodes a tegument protein, an orthologue of HSV1 protein UL47 which is highly conserved among alphaherpesviruses. Che et al. used deletion mutant to show that ORF11 an important VZV virulence determinant for skin (J. Virol. 82, 5825–5834 (2008).). Only rabbit sera was available to analyze the ORF11 before we generated VZV mAbeom. Our anti-VZV11 antibody VZ 11N.12 shows that during infection VZV ORF11 protein localizes to Golgi network. Our anti-VZV11 antibody VZ 11N.12 works in ELISA (on immunogen), IF (on VZV infected cells) and each LOT is validated for Western blot of VZV infected lysates, where itrecognizes a protein of ~110 kDa (described in J Virol. 2013 Jun;87(12):6943-54.).
Clone: VZ 11N.12
Catalog No.: HR-VZV-07
Host Species: Mouse
Reactivity: Varicella zoster virus
Antigen/Immunogen: The immunogen consisted of ORF11 N terminal domain (amino acids 1-400) and was produced in E.coli
Tested Applications: ELISA; IF; WB
Recommended Dilution: n/a
Varicella zoster virus
The immunogen consisted of ORF11 N terminal domain (amino acids 1-400) and was produced in E.coli
ELISA; IF; WB
€200.00 – €700.00
|STORAGE||Long term -20 °C, short term +4 °C. Avoid freeze-thaw cycles.|
|LIGHT CHAIN TYPE||kappa|
|REFERENCES||Lenac et al., J Virol, 2013|
Open reading frame 37 (ORF37) of Varicella zoster encodes for envelope glycoprotein H (gH). VZV gH is a 118kDa type 1 transmembrane glycoprotein highly conserved among other alphaherpesviruses.
VZV ORF27 encodes a nuclear egress lamina protein, that together with the nuclear egress membrane protein encoded by the product of VZV ORF27, most likely plays a role in the egress of assembled viral capsids from the nuclei of VZV infected cells to the cytoplasm.
VZV ORF33.5 encodes a scaffold protein involved in the assembly of the viral capsid. ORF33.5 has the capacity to mediate ORF40 translocation into the nucleus of VZV-infected cells and exhibits a nuclear localization phenotype.
The ORF50 gene of the varicella-zoster virus (VZV) encodes glycoprotein M which is conserved among all herpesviruses. VZV gM is predicted to be an eight-transmembrane envelope glycoprotein modified with a complex N-linked oligosaccharide.